These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11981373

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J.
    Science; 1997 Jul 04; 277(5322):112-6. PubMed ID: 9204894
    [Abstract] [Full Text] [Related]

  • 4. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection.
    Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R.
    AIDS; 1998 Oct 01; 12(14):1833-44. PubMed ID: 9792384
    [Abstract] [Full Text] [Related]

  • 5. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Benito JM, López M, Martín JC, Lozano S, Martínez P, González-Lahoz J, Soriano V.
    AIDS Res Hum Retroviruses; 2002 Dec 10; 18(18):1379-88. PubMed ID: 12487809
    [Abstract] [Full Text] [Related]

  • 6. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
    García F, Plana M, Vidal C, Cruceta A, O'Brien WA, Pantaleo G, Pumarola T, Gallart T, Miró JM, Gatell JM.
    AIDS; 1999 Jul 30; 13(11):F79-86. PubMed ID: 10449278
    [Abstract] [Full Text] [Related]

  • 7. Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
    Plana M, Martínez C, García F, Maleno MJ, Barceló JJ, García A, Lejeune M, Vidal C, Cruceta A, Miró JM, Pumarola T, Gallart T, Gatell JM.
    J Acquir Immune Defic Syndr; 2002 Apr 15; 29(5):429-34. PubMed ID: 11981357
    [Abstract] [Full Text] [Related]

  • 8. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 9. CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy.
    Meroni L, Varchetta S, Manganaro D, Moscatelli G, Moroni M, Galli M.
    AIDS; 1999 Apr 01; 13(5):621-2. PubMed ID: 10203388
    [No Abstract] [Full Text] [Related]

  • 10. [Antiretroviral therapy in patients infected with HIV-1].
    Corti ME.
    Medicina (B Aires); 1998 Apr 01; 58 Suppl 1():49-56. PubMed ID: 9674248
    [No Abstract] [Full Text] [Related]

  • 11. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
    Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M, Kotzin BL, Fox L, Chiozzi MH, Leonard JM, Rousseau F, Wade M, Roe JD, Martinez A, Kessler H.
    J Infect Dis; 1998 Jul 01; 178(1):70-9. PubMed ID: 9652425
    [Abstract] [Full Text] [Related]

  • 12. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
    Evans TG, Bonnez W, Soucier HR, Fitzgerald T, Gibbons DC, Reichman RC.
    Antiviral Res; 1998 Oct 01; 39(3):163-73. PubMed ID: 9833957
    [Abstract] [Full Text] [Related]

  • 13. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.
    AIDS; 2000 Sep 08; 14(13):1921-33. PubMed ID: 10997396
    [Abstract] [Full Text] [Related]

  • 14. Vaccination and HIV-1 replication during highly active antiretroviral therapy.
    Kroon FP, Beersma MF, Kroes AC, Groeneveld PH, van Dissel JT.
    AIDS; 1999 Jan 14; 13(1):135-6. PubMed ID: 10207556
    [No Abstract] [Full Text] [Related]

  • 15. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.
    Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Muratori DS, Bernardi ML, Paganelli R, Aiuti F.
    AIDS; 1999 Jul 09; 13(10):1187-93. PubMed ID: 10416521
    [Abstract] [Full Text] [Related]

  • 16. Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.
    Barreiro PM, Dona MC, Castilla J, Soriano V.
    AIDS; 1999 Mar 11; 13(4):525-6. PubMed ID: 10197384
    [No Abstract] [Full Text] [Related]

  • 17. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S, Otto SA, Knol GJ, Manting EH, Nanlohy NM, Jansen C, Lange JM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2002 Apr 11; 32(4):1080-9. PubMed ID: 11920575
    [Abstract] [Full Text] [Related]

  • 18. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Asjö B.
    AIDS Res Hum Retroviruses; 2000 Feb 10; 16(3):191-201. PubMed ID: 10710207
    [Abstract] [Full Text] [Related]

  • 19. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V, Süsal C, Melk A, Weimer R, Kröpelin M, Zimmermann R, Huth-Kühne A, Uhle C, Opelz G.
    Immunol Lett; 1999 Aug 03; 69(2):283-9. PubMed ID: 10482364
    [Abstract] [Full Text] [Related]

  • 20. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
    Levacher M, Bouscarat F, Landman R, Chau F, Damond F, Gaudebout C, Mathez D, Leibowitch J, Saimot AG, Sinet M.
    AIDS Res Hum Retroviruses; 2000 Nov 20; 16(17):1869-75. PubMed ID: 11118072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.